Endra Life Sciences INC. (NDRA) — 8-K Filings

All 8-K filings from Endra Life Sciences INC.. Browse 23 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (23)

8-K Filing — Apr 21, 2026
ENDRA Life Sciences Reports Exit/Disposal Activities in 8-K — Mar 25, 2026
ENDRA Life Sciences Inc. filed an 8-K on March 25, 2026, reporting activities related to Item 2.05 (Costs Associated with Exit or Disposal Activities) and Item
8-K Filing — Dec 15, 2025
8-K Filing — Nov 28, 2025
ENDRA Life Sciences Files 8-K for Material Agreement — Oct 30, 2025 Risk: medium
ENDRA Life Sciences Inc. filed an 8-K on October 30, 2025, reporting an event that occurred on October 29, 2025. The filing indicates an entry into a material d
ENDRA Life Sciences Files 8-K — Oct 23, 2025 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on October 23, 2025, reporting on various events. The filing includes information related to financial statements and exhi
ENDRA Life Sciences Files 8-K — Jul 23, 2025 Risk: medium
ENDRA Life Sciences Inc. filed an 8-K on July 23, 2025, to report other events. The filing does not contain specific details about the nature of these events, d
ENDRA Life Sciences Files 8-K on Financials — Jul 9, 2025 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on July 9, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
ENDRA Life Sciences Files 8-K for Regulation FD Disclosure — Jun 11, 2025 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on June 11, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material
ENDRA Life Sciences Faces Delisting Concerns — May 30, 2025 Risk: high
ENDRA Life Sciences Inc. filed an 8-K on May 30, 2025, reporting a notice of delisting or failure to meet continued listing standards. The company's principal e
ENDRA Life Sciences Files 8-K — Nov 22, 2024 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on November 22, 2024, reporting on other events and financial statements. The filing details the company's principal execu
ENDRA Life Sciences Files 8-K on Financials — Nov 15, 2024 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on November 15, 2024, reporting on its results of operations and financial condition. The filing includes financial statem
ENDRA Life Sciences Files 8-K on Security Holder Rights — Nov 5, 2024 Risk: medium
ENDRA Life Sciences Inc. filed an 8-K on November 4, 2024, reporting material modifications to the rights of security holders and amendments to its articles of
ENDRA Life Sciences Files 8-K on Corporate Matters — Oct 29, 2024 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on October 29, 2024, reporting on matters submitted to a vote of security holders and other events that occurred on Octobe
ENDRA Life Sciences Files 8-K — Aug 28, 2024 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on August 28, 2024, reporting on various events. The filing includes information related to Regulation FD disclosures, oth
ENDRA Life Sciences Files 8-K on Financials — Aug 23, 2024 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on August 23, 2024, reporting on its results of operations and financial condition as of August 22, 2024. The filing inclu
ENDRA Life Sciences Files 8-K with Corporate Updates — Aug 16, 2024 Risk: medium
ENDRA Life Sciences Inc. filed an 8-K on August 16, 2024, reporting material modifications to the rights of security holders and amendments to its articles of i
ENDRA Life Sciences Appoints New CEO, Directors, and Incentive Plan — Aug 13, 2024 Risk: medium
ENDRA Life Sciences Inc. announced on August 12, 2024, a series of significant corporate actions. These include the election of two new directors, Dr. Jonathan
Samsung Medical to Acquire ENDRA Life Sciences for $50M — Aug 9, 2024 Risk: medium
ENDRA Life Sciences Inc. announced on August 5, 2024, that it has entered into a definitive agreement to be acquired by a subsidiary of Samsung Medical for appr
ENDRA Life Sciences Faces Delisting Notice — Jul 17, 2024 Risk: high
ENDRA Life Sciences Inc. filed an 8-K on July 17, 2024, reporting a notice of delisting or failure to meet continued listing standards as of July 15, 2024. The
ENDRA Life Sciences Files 8-K: Material Agreement — Jun 6, 2024 Risk: medium
ENDRA Life Sciences Inc. announced on June 4, 2024, that it entered into a material definitive agreement. The company also disclosed information related to Regu
ENDRA Life Sciences Files 8-K — May 20, 2024 Risk: low
ENDRA Life Sciences Inc. filed an 8-K on May 20, 2024, reporting on other events and financial statements. The filing does not contain specific dollar amounts o
ENDRA Life Sciences Faces Delisting Concerns — May 3, 2024 Risk: high
ENDRA Life Sciences Inc. filed an 8-K on May 3, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is incorporate

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX